Company news
Conneqt Health Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
CardieX and inHealth Collaboration in Landmark US Study
April 2, 2019
CardieX Corporate Update and Report from CEO
March 31, 2019
CardieX Announces Expansion of Bayer Pharma Trial Contract
March 6, 2019
Appendix 4D Half Year Report
February 28, 2019
CardieX Update on the Acquisition of 50.5% of inHealth
February 1, 2019
Convertible Note Application Received from C2 Ventures
January 22, 2019
Response to ASX Aware Query
January 17, 2019
Cardiexs inHealth Executes Major Co-Marketing Agreement
January 14, 2019
CardieXs inHealth Signs LOI With Global Electronics Company
December 17, 2018
CardieX Signs Agreement for Wearable Sensor Development
December 11, 2018
CardieX Successfully Closes Oversubscribed $5.5m Fundraising
December 5, 2018
CEO Strategy Overview and 2019 Plan
December 2, 2018
CardieX Owned inHealth Partners with Kaiser Permanente
November 28, 2018
CardieX Corporate Update & Overview of inHealth Transaction
November 11, 2018
CardieX Partner Blumio Initiates Large Scale Clinical Trial
October 31, 2018
New Medical Devices Supply Contract with AstraZeneca
October 26, 2018
CardieX Subsidiary Wins New Medical Devices Supply Contract
October 25, 2018
Acquisition of Major Stake in inHealth Medical
October 15, 2018
Receipt of Subscription Proceeds from C2 Ventures Pty Ltd
October 11, 2018
CardieX Appendix 4E and 2018 Annual Financial Statements
August 31, 2018
CardieX Reports Successful Trial Results for Wearable Sensor
July 24, 2018
CardieX Makes First Investment in Wearable Tech Partnership
June 18, 2018
CardieX (AtCor) Entitlements Issue Heavily Over Subscribed
June 12, 2018
AtCor Announces Wearable Trial with Macquarie University
May 21, 2018
Blumio Wearable Cardio Trial with Macquarie University
May 20, 2018
Underwritten Rights Issue Prospectus Lodged with ASIC
April 23, 2018
Oversubscribed Capital Raising to Fast Track New Strategy
April 22, 2018
AtCor Announces First Steps in Major Strategic Repositioning
March 14, 2018
AtCors XCEL device clinically validated in 3rd party study
January 23, 2018
AtCor and PhysioAge Systems announce supply agreement
January 10, 2018
AtCor secures $1.0 million new pharmaceutical trial contract
December 14, 2017
AtCor appoints Craig Cooper as CEO
November 30, 2017
Chairmans address to 2017 AGM
November 29, 2017
Tax Refund
October 30, 2017
Security Purchase Plan
September 7, 2017
Full Year Statutory Accounts
August 31, 2017
Share Purchase Plan
August 29, 2017
Share Placement
August 8, 2017
AtCor restructures operations
August 2, 2017
AtCor Signs New Agreement
July 31, 2017
Secures $0.8 million new pharmaceutical trials contracts
July 12, 2017
AtCor Signs New Network Health Systems Agreement
June 6, 2017
Business update and Strategic Review
May 18, 2017
AtCor Signs Local Health System Agreement
February 23, 2017
Study Finds Central Aortic Waveform Improves HF Treatment
February 15, 2017
Tax refund
February 13, 2017
Positive Novartis drug trial using SphygmoCor XCEL
January 22, 2017
AtCor completes share placement
November 15, 2016
Leading research team highlights role of SphygmoCor
November 4, 2016
FY2016 results
August 29, 2016
Decks
The 5 newest of 9 decks. Every deck is listed under its year.
- Shareholder Meeting (September 2026)
Shareholder meeting · 26 slides · Sep 15, 2026
- Investor Presentation (July 2026)
Investor deck · 21 slides · Jul 22, 2026
- Investor Presentation (May 2026)
Investor deck · 31 slides · May 1, 2026
- Investor Presentation (May 2025)
Investor deck · 39 slides · May 30, 2025
- Investor Presentation (December 2023)
Investor deck · 46 slides · Dec 19, 2023